0 Komentáře
0 Sdílení
6K Shlédnutí
0 Hodnocení
Hledat
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Komentáře 0 Sdílení 930 Shlédnutí 0 Hodnocení
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Komentáře 0 Sdílení 872 Shlédnutí 0 Hodnocení
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení1
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Komentáře 0 Sdílení 2K Shlédnutí 0 Hodnocení
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Komentáře 0 Sdílení 749 Shlédnutí 0 Hodnocení1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Komentáře 0 Sdílení 755 Shlédnutí 0 Hodnocení1
-
In-Depth Growth Drivers and Strategic Trends in the Breast Cancer Therapeutics Market Developments and Forecast by 2030The Breast Cancer Therapeutics Market is witnessing substantial growth as healthcare systems worldwide intensify efforts to combat one of the most prevalent cancers affecting women. Driven by rising incidence rates, improved diagnostic capabilities, and a strong pipeline of innovative therapies, the market is positioned for remarkable expansion over the next decade. According to industry...0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení
-
Market Intelligence: Basal Cell Carcinoma Treatment Trends and DriversHealthcare infrastructure improvements are enhancing access to skin cancer treatments.Specialized dermatology centers are expanding globally.This accessibility is contributing to increased treatment adoption The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market...0 Komentáře 0 Sdílení 4K Shlédnutí 0 Hodnocení1
-
Market Outlook 2025–2031: Future of Sarcoma Drug DevelopmentOrphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Komentáře 0 Sdílení 5K Shlédnutí 0 Hodnocení1
More Results